Fluorescein and Benoxinate Ophthalmic Solution

Generic name: fluorescein sodium and benoxinate hydrochloride
Dosage form: ophthalmic solution
Drug class:Ophthalmic diagnostic agents

Medically reviewed by Drugs.com. Last updated on Feb 21, 2022.

Indications and Usage for Fluorescein and Benoxinate Ophthalmic Solution

Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4% is indicated for ophthalmic procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent.

Fluorescein and Benoxinate Ophthalmic Solution Dosage and Administration

Instill 1 to 2 drops topically in the eye as needed.

Dosage Forms and Strengths

Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4% is a yellow to orange-red ophthalmic solution containing fluorescein sodium 2.6 mg/mL (0.3%) and benoxinate hydrochloride 4.4 mg/mL (0.4%).

Contraindications

Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4% is contraindicated in patients with known hypersensitivity to any component of this product.

Warnings and Precautions

Corneal Toxicity

Prolonged use or abuse may lead to corneal epithelial toxicity and may manifest as epithelial defects which may progress to permanent corneal damage with accompanying visual loss.

Corneal Injury due to Insensitivity

Patients should not touch the eye for approximately 20 minutes after using this anesthetic as accidental injuries can occur due to insensitivity of the eye.

Adverse Reactions

The following serious ocular adverse reactions are described elsewhere in the labeling:

•

Corneal Toxicity ...